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Abstract: Microorganisms that inhabit unchartered unique soil such as in the highly saline and
hot Red Sea lagoons on the Saudi Arabian coastline, represent untapped sources of potentially
new bioactive compounds. In this study, a culture-dependent approach was applied to three types
of sediments: mangrove mud (MN), microbial mat (MM), and barren soil (BS), collected from
Rabigh harbor lagoon (RHL) and Al-Kharrar lagoon (AKL). The isolated bacteria were evaluated
for their potential to produce bioactive compounds. The phylogenetic characterization of 251
bacterial isolates based on the 16S rRNA gene sequencing, supported their assignment to five
different phyla: Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes, and Planctomycetes. Fifteen
putative novel species were identified based on a 16S rRNA gene sequence similarity to other strain
sequences in the NCBI database, being ≤98%. We demonstrate that 49 of the 251 isolates exhibit
the potential to produce antimicrobial compounds. Additionally, at least one type of biosynthetic
gene sequence, responsible for the synthesis of secondary metabolites, was recovered from 25 of the
49 isolates. Moreover, 10 of the isolates had a growth inhibition effect towards Staphylococcus aureus,
Salmonella typhimurium and Pseudomonas syringae. We report the previously unknown antimicrobial
activity of B. borstelensis, P. dendritiformis and M. salipaludis against all three indicator pathogens.
Our study demonstrates the evidence of diverse cultured microbes associated with the Red Sea
harbor/lagoon environments and their potential to produce antimicrobial compounds.
Keywords: Red Sea; mangrove mud; microbial mat; barren soil; culturable bacteria;
phylogenetic diversity; 16S rRNA; firmicutes; bioactivity; antimicrobial compounds; biosynthetic
genes; bioinformatics
1. Introduction
The imprudent use of antibiotics to treat infectious diseases, along with their widespread use in
agriculture and food manufacturing industries, has caused an increase in pathogen resistance which
now poses a global public health threat associated with an increase in mortality rates and health care
costs [1]. Unfortunately, the successes of screening soil actinomycetes for diffusible broad-spectrum
antibiotic agents in the 1940s–1960s has met with diminishing returns, as in several instances, active
compounds identified from screening assays have led to previously described compounds. Since the
1960s, only two new classes of antibiotics, the cyclic lipopeptide daptomycin, identified by a classical
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screening approach [2] and linezolid (a completely synthetic oxazolidinone) [3], have been successfully
introduced to the clinic [4]. Since type-I polyketide synthases (PKS-I) and nonribosomal peptide
synthetases (NRPS) have been found to support synthesis of secondary metabolites that act as
antibiotics, immunosuppressants, toxins, siderophores, or antitumor agents, research is increasingly
being focused on identifying microorganisms that harbor these multimodular enzymes [5] (see Table 1).
The presence of these genes in the genome does not necessarily imply their expression or function, but
does increase chances of identifying organisms capable of producing the above-mentioned bioactive
compounds. Nonetheless, marine species that live in habitats with stressful conditions such as low
light, low or high temperature, high pressure and salinity, produce different arrays of bioactive
secondary metabolites that help them to survive [6], provide defense against other organisms, and help
in the competition for food. These species represent an insufficiently explored source of organisms
with potential to produce compounds high with antimicrobial activity.
Several recent studies have screened for antimicrobial compounds produced by microorganisms
isolated from natural environments such as in hydrothermal vents [7], sediments [8], plants [9],
seawater [10], and eukaryotic marine organisms [11]. This broader screening approach has successfully
identified promising new antibiotics [12–14]. Research targeting sediments has sparked particular
interest as soil compositions direct the diversity of the inhabiting microbial communities and their
potential to produce antimicrobial compounds. Thus, microorganisms that inhabit unexplored unique
soil compositions, such as in the Rabigh harbor lagoon (RHL) and Al-Kharrar lagoon (AKL) of
the highly saline and hot Red Sea, represent untapped reservoirs of organisms that potentially
produce novel bioactive compounds. RHL and AKL are located on the eastern coast of the Red
Sea in Saudi Arabia. Previously, studies related to the sediment configuration of these lagoons have
been reported [15–18]. Additionally, Red Sea mangrove metagenomics [19–22] have characterized
biodiveristy or bioactivity as induced by Red Sea bacteria [11,23–25]. Nonetheless, both the lagoons
have a higher nutrient content and organic matter when compared to the open sea, making their
environments more favorable for this type of research. Additionally, RHL is considered a contaminated
site owing to it being used as a harbor and being located near Petro Rabigh (Refining and Petrochemical
Company), whereas AKL is considered less contaminated because its coast is poorly inhabited and
only minor fishing activity is present in the lagoon.
Table 1. Nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) compounds
derived from microbes.
Compound Enzyme Source Activity Reference
Bacitracin NRPS Bacillus spp. Antibacterial [26]
Surfactin NRPS Bacillus subtilis Antibacterial [27]
Macrolactin PKS Bacillus amyloliquefaciens Antibacterial [28]
Mupirocin PKS Pseudomonads fluorescens Antibacterial [29]
Retimycin NRPS Sallinispora arenicola Antitumor [30]
Pederin PKS Paederus fuscipes Antitumor [31]
Salinosporamide K NRPS Salinispora pacifica Antitumor [32]
Salinilactam A PKS Salinispora tropica Antitumor [33]
Bryostatin PKS Candidatus Endobugula sertula Antitumor [34]
In this study, we sampled sediments from three Red Sea environments: mangrove mud (MN),
microbial mat (MM), and soil (BS) collected from the RHL and AKL. A culture-dependent approach
was applied to these sediment samples for the isolation and identification of microorganisms using
16S rRNA gene sequencing. We have also reported their capacity to inhibit the growth of three
laboratory pathogens, Staphylococcus aureus ATCC 25923, Pseudomonas syringae pv. tomato dc3000,
and Salmonella typhimurium dT2, as well as their genomic potential to produce secondary metabolites
with antimicrobial activity.
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2. Results and Discussion
2.1. Bacterial Isolation
Characterizing microbial communities in sediment is a difficult task, mostly because of their
huge genotypic and phenotypic diversity and heterogeneity [35]. In the top layer of soil, the bacterial
inhabitants can be present in densities exceeding 109 cells/g soil [35], and most of these strains
seem to be unculturable. It is estimated that live culture techniques address 0.01%–1% of existing
microbial diversity [20,36,37]. Only cultivated strains have been studied in detail [35,38], yet they
represent less than 5% of the total microbial biomass in the soil [39]. Thus, in an attempt to broaden
the diversity of the isolated strains, we employed several culture media: Difco marine agar 2216 (MA),
10% Difco marine agar 2216 (10% MA), Difco Marine agar 2216 with 1 g/L streptomycin (Anti-MA),
actinomycetes isolation agar (AIA) and Difco marine broth 2216 gellan gum (MB-GM). Bacterial
colonies grew fast on MA, exhibiting a more diverse colony morphology and density than on other
media. Growth on the 10% MA medium tended to be similar to MA, but less diverse, while only a
small number of colonies grew on Anti-MA and AIA. However, the growth in MB-GM was faster
than in an agar-based media. This finding is not surprising as several studies have shown MB-GM
to be more successful in isolating bacterial species from marine environments [40], and may isolate
specifically rare actinomycetes [41,42]. Isolates were selected for propagation based on morphological
distinctiveness (Supplementary Table S1).
2.2. 16S rRNA Gene Sequencing and Phylogenetic Analysis
The 16S rRNA gene of the 251 isolated and purified bacterial strains, was sequenced as a taxonomic
marker. Our analysis revealed that 16S rRNA gene sequences for all the strains showed similarity
with 16S rRNA gene sequences deposited in the National Center for Biotechnology Information
(NCBI) GenBank database in the range of 91%–100% (see Figure 1 and Supplementary Figure S1).
The taxonomic classification placed the 251 isolates into five phyla comprising 32 genera: Firmicutes
(135 strains; 12 genera), Proteobacteria (99 strains; 11 genera), Planctomycetes (six strains; two genera),
Actinobacteria (six strains; four genera) and Bacteroidetes (five strains; three genera) (Figure 2).
Firmicutes and Proteobacteria were isolated from all three types of sediments. Interestingly, the
number of cultured Proteobacteria decreased in the three sediment types, which is in accordance with
the reduction of the sediments exposure to seawater. In contrast, the number of cultured Firmicutes
increased in the three sediment types, in accordance with the sediments exposure to seawater. The
contrasting counts, for Proteobacteria and Firmicutes in these different sediments types, may be due to
the spore-producing Firmicutes ability to survive in more adverse oligotrophic environments such
as in BS compared to MN [43]. Additionally, Proteobacteria has the known ability to utilize chemical
elements in soil more than other microorganisms, which makes the nutrient rich MN sediment more
favorable for this phylum [44,45]. Bacteria from the Actinobacteria phylum were isolated from BS
at RHL, and from MN collected from RHL and AKL, while Bacteroidetes were only isolated from
BS collected from both locations. Planctomycetes were cultured from various sites such as MM and
BS at RHL, and MN at AKL. The Firmicutes genus Bacillus was the predominant taxon isolated from
all samples, especially from BS (Supplementary Table S1). The Bacillus species, recognized as an
important source of natural bioactive products [46], are commonly found in nutrient-poor soils [47].
We found that the most abundant cultured and widely distributed species in RHL and AKL were:
Bacillus subtilis, Bacillus sonorensis and Bacillus licheniformis. In addition, Virgibacillus pantothenticus,
Microbulbifer maritimus, Bacillus foraminis, Vibrio alginolyticus and Vibrio furnissii strains were isolated
three times or more from MN only.









Out  of  the  251  isolates,  15  could  be  considered  putative  novel  species  as  they  have  ≤98% 
similarity  to  16S  rRNA  gene  sequences  deposited  in  GenBank  [48–51]  (Table  2,  Figure  1).  The 
taxonomic classification placed the 15 isolates into five phyla comprising 12 genera and 15 species: 
Proteobacteria (Vibrio alginolyticus, Microbulbifer maritimus, Microbulbifer gwangyangensis, Oceanicaulis 
sp.,  Marinobacter  xestospongiae,  Pseudoalteromonas  espejiana,  Pseudoalteromonas  flavipulchra, 
Pseudoalteromonas  atlantica),  Firmicutes  (Bacillus  simplex  and  Exiguobacterium  profundum), 
Planctomycetes  (Planctomyces  brasiliensis,  Planctomycete  sp.,  Blastopirellula  cremea),  Actinobacteria 
(Brevibacterium  avium)  and  Bacteroidetes  (Flavobacteriaceae  bacterium).  Interestingly,  11  of  the  15 
putative novel species were isolated from the 10% MA medium. Thus, low nutrient media may be 
more  suitable  for  targeting  the  isolation  of  those  bacteria  that  are more difficult  to  culture—the 
rationale  being  that  it  provides  an  environment  that  does  not  facilitate  the  growth  of  easily 
culturable bacteria  that  thrive  in high nutrient media and usually overshadow or outcompete  the 
so‐called “unculturable” bacteria. Moreover, from the putative novel species, 53.3% have a genetic 
i r 1. l ti tr s i t relati s i f the 15 putative novel species. e seq e c
li ent was performed using the SINA online tool and trees were built in the software envir nment
for sequence data called ARB, st rting from the ribosomal RNA gene database called SILVA SSU datas t
Ref NR 99 (version 119) using MrBayes with 100,000 M rkov Chain Monte Carlo (mcmc) cycles.
Out of the 251 isolates, 15 could be considered putative novel species as they have≤98% similarity
to 16S rRNA gene sequences deposited in GenBank [48–51] (Table 2, Figure 1). The taxonomic
classification placed the 15 isolates into five phyla comprising 12 genera and 15 species: Proteobacteria
(Vibrio alginolyticus, Microbulbifer maritimus, Microbulbifer gwangyangensis, Oceanicaulis sp., Marinobacter
xestospongiae, Pseudoalteromonas espejiana, Pseudoalteromonas flavipulchra, Pseudoalteromonas atlantica),
Firmicutes (Bacillus simplex and Exiguobacterium profundum), Planctomycetes (Planctomyces brasiliensis,
Planctomycete sp., Blastopirellula cremea), Actinobacteria (Brevibacterium avium) and Bacteroidetes
(Flavobacteriaceae bacterium). Interestingly, 11 of the 15 putative novel species were isolated from
the 10% MA medium. Thus, low nutrient media may be more suitable for targeting the isolation of
those bacteria that are more difficult to culture—the rationale being that it provides an environment
that does not facilitate the growth of easily culturable bacteria that thrive in high nutrient media
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and usually overshadow or outcompete the so-called “unculturable” bacteria. Moreover, from the
putative novel species, 53.3% have a genetic affiliation with the phylum Proteobacteria, and 13.3%
have a genetic affiliation with the phylum Firmicutes. Interestingly, 75.0% of putative novel strains

















Phylum  Location  Sediment   
Type  Media 
Bac34  98% Vibrio alginolyticus  1429  Proteobacteria  RHL  MN  10% MA 
Bac56  98% Microbulbifer maritimus  1390  Proteobacteria  RHL  MN  10% MA 
Bac77  98% Pseudoalteromonas flavipulchra  1406  Proteobacteria  RHL  MM  10% MA 
Bac85  95% Microbulbifer gwangyangensis  1406  Proteobacteria  RHL  MM  10% MA 
Bac92  97% Planctomyces brasiliensis  1372  Planctomycete  RHL  MM  Anti‐MA 
Bac94  98% Bacillus simplex  1423  Firmicutes  RHL  MM  10% MA 
Bac120  98% Oceanicaulis sp.  1336  Proteobacteria  RHL  BS  10% MA 
Bac131  98% Planctomycete sp.  1417  Planctomycete  RHL  BS  Anti‐MA 
Bac140  97% Flavobacteriaceae bacterium  1394  Bacteroidetes  RHL  BS  10% MA 
Bac175  98% Blastopirellula cremea  1385  Planctomycete  AKL  MN  Anti‐MA 
Bac181  91% Brevibacterium avium  1341  Actinobacteria  AKL  MN  AIA 
Bac216  97% Marinobacter xestospongiae  1414  Proteobacteria  AKL  MM  10% MA 
Bac319  98% Pseudoalteromonas espejiana  1380  Proteobacteria  RHL  MM  10% MA 
Bac320  98% Pseudoalteromonas atlantica  1392  Proteobacteria  RHL  MM  MB‐GM 
Bac387  96% Exiguobacterium profundum  1327  Firmicutes  RHL  MN  10% MA 





In  order  to  defend  themselves  against  other  microorganisms,  bacteria  produce  different 
compounds. Many  of  these metabolites  are  bioactive  compounds  and  some  have  antimicrobial 
activity [52]. Within this context, we evaluated all 251 isolates for their antimicrobial activity against 
three  pathogens:  Staphylococcus  aureus  ATCC25923,  Pseudomonas  syringae  dc3000,  and  Salmonella 
typhimurium dT2. The  reason  behind  the  selection of  these pathogens was  to  cover  the different 
spectrum of antimicrobial use. S. aureus causes several human  infections such as skin and wound 
infections, septicemia, endocarditis, food poisoning, toxic shock syndrome, meningitis, pneumonia 
Figure 2. Overview of cultured microorganisms, at phylum level, isolated from Rabigh and
Al-Kharrar sediments.
Table 2. 16S rRNA gene taxonomic affiliation of the putative novel isolated strains.
Strain
ID
% Similarity of 16S rRNA
Sequences to GenBank Strains:
Numb r of
Nucleotides (bp) Phylum Location
Sediment
Type Media
i i l i l 1429 Proteobacteria RHL MN 10% MA
i l if i i 1390 Proteobacteria RHL MN 10% MA
Bac77 98 Pseudoaltero onas flavipulchra 1406 Proteobacteria RHL M 10% MA
Bac85 95% Microbulbifer gwangyangensis 1406 Proteobacteria RHL MM 10% MA
Bac92 97% Planctomyces brasiliensis 1372 Planctomycete RHL MM Anti-MA
Bac94 98% Bacillus simplex 1423 Firmicutes RHL MM 10% MA
Bac120 98% Oceanicaulis sp. 1336 Proteobacteria RHL BS 10% MA
Bac131 98% Planctomycete sp. 1417 Planctomycete RHL BS Anti-MA
ac140 97% Flavobacteriaceae bacterium 1394 Bacteroidetes RHL BS 10% MA
75 98% Blastopirellula cremea 1385 Planctomycete AKL MN Anti-MA
81 1 revibacterium avium 1341 Actinobacteria AKL MN AI
Bac216 97% Marinobacter xestospongiae 1414 Proteobacteria AKL MM 10% MA
Bac319 98% Pseudoalteromonas espejiana 1380 Proteobacteria RHL MM 10% MA
Bac320 98% Pseudoalteromonas atlantica 1392 Proteobacteria RHL MM MB-GM
Bac387 96% Exiguobacterium profundum 1327 Firmicutes RHL MN 10% MA
Abbreviations: RHL: Rabigh harbor lagoon; AKL: Al-Kharrar lagoon MN: mangrove mud; MM: microbial
mat; BS: barren soil; 10% MA: 10% Difco Marine agar 2216; Anti-MA: Difco Marine agar 2216 with 1 g/L
streptomycin; AIA: actinomycetes isolation agar; MB-GM: Difco Marine broth 2216 gellan gum media.
2.3. Antimicrobial Screening
In order to defend themselves against other microorganisms, bacteria produce different
compounds. Many of these metabolites are bioactive compounds and some have antimicrobial
activity [52]. Within this context, we evaluated all 251 isolates for their antimicrobial activity against
three pathogens: Staphylococcus aureus ATCC25923, Pseudomonas syringae dc3000, and Salmonella
typhimurium dT2. The reason behind the selection of these pathogens was to cover the different
spectrum of antimicrobial use. S. aureus causes several human infections such as skin and wound
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infections, septicemia, endocarditis, food poisoning, toxic shock syndrome, meningitis, pneumonia
and osteomyelitis [53]. Additionally, the strain S. aureus ATCC 25923 is commonly used as a control
to test for antibiotic susceptibility, and as a quality control strain for commercial products [54].
P. syringae pv. tomato dc3000 is a phytopathogen used as a model to study plant-bacterial
interactions [55]. S. enterica serovar typhimurium definitive type 2 (DT2) is host restricted to Columba
livia (rock or feral pigeon). However, it is also closely related to S. typhimurium isolates that circulate in
livestock and causes zoonosis, that is, gastroenteritis in humans [56].
Of the 251 isolates screened, 49 isolates showed potential antimicrobial activity evidenced
through growth inhibition against at least one of the indicator pathogens (included in Supplementary
Table S3). These isolates belong to 12 genera of the phylum Firmicutes (genera: Bacillus, Virgibacillus,
Brevibacillus, Aneurinibacillus, Staphylococcus, Paenibacillus), Proteobacteria (genera: Microbulbifer,
Salinivibrio, Pseudoalteromonas, Pseudomonas, Stenotrophomonas) and Bacteroidetes (genus: Pontibacter).
It is noteworthy that, of these 49 isolates, 67.0% were isolated from RHL and 48.9% have a genetic
affiliation to genus Bacillus.
Of all isolates, 42 inhibited the growth of S. aureus, 14 isolates inhibited the growth of
S. typhimurium and 34 isolates inhibited the growth of P. syringae. Only 10 isolates displayed zone
inhibition against all of the three indicator laboratory pathogens (Table 3), of which nine isolates belong
to the phylum Firmicutes, while one belongs to the phylum Proteobacteria (Microbulbifer salipaludis
(Bac177)). Of these 10 isolates, only zone inhibition for B. licheniformis (Bac84) and A. migulanus
(Bac271) showed an annular radius of ≥3.0 mm for all screenings, suggesting a higher activity against
all three indicator laboratory pathogens. However, the strain Bac177 of M. salipaludis displayed the
most effective zone inhibition against S. typhimurium. Two strains, Bac57 and Bac376, belonging
to the species Bacillus amyloliquefaciens and Virgibacillus olivae, respectively, displayed strain-specific
activity as shown by an annular radius of ≥3.0mm against P. syringae. Additionally, strains Bac389,
Bac375 and Bac380 belonging to Bacillus cereus, Pseudomonas fluorescens and Stenotrophomonas maltophilia
respectively, displayed strain-specific activity as shown by an annular radius of ≥3.0 mm against
S. aureus. Of the putative novel strains, only a strain (Bac319) of Pseudoalteromonas espejiana displayed
zone inhibition as shown by an annular radius of ≥1.0 mm against S. aureus, and a strain (Bac320) of
Pseudoalteromonas atlantica revealed zone inhibition as shown by an annular radius of ≥1.0 mm against
S. aureus and P. syringae.
Some of the ten strains that inhibited the growth of the three tested pathogens are already
known to be producers of bioactive compounds. For example, Gramicidin S, a cyclodecapeptide
recently isolated from A. migulanus [57], was originally isolated from the Gram-positive Bacillus
brevis and was shown to exhibit an antibiotic effect against some Gram-positive and Gram-negative
bacteria, as well as some fungi [58]. In addition, B. licheniformis is used for several biotechnological
applications for its capacity to produce degrading enzymes such as proteases, lipases, pectate lyases,
and polysaccharides [59]. B. licheniformis has further been shown to exhibit potent antimicrobial
activity against indicator strains (Lactococcus lactis, Lactobacillus bulgaricus and Listeria innocua) and
is clinically relevant (Listeria monocytogenes, Staphylococcus aureus, Streptococcus agalactiae, Salmonella
Typhimurium and Escherichia coli) bacteria [60]. B. subtilis is a recognized producer of natural biocontrol
agents, having high antifungal activity against Alternaria solani, Botrytis cinerea, Monilia linhartiana
869, Phytophthora cryptogea 759/1 and Rhizoctonia sp., and antibacterial activity against Pseudomonas
syringae pv. tomato Ro and Xanthomonas campestris [61]. B. sonorensis has displayed antifungal activity
against Macrophomina phaseolina [62] and has been shown to exhibit antibacterial activity against
Staphylococcus aureus and Listeria monocytogenes as a potential food preservative [63]. B. vallismortis
showed strong growth inhibition activity in vitro against the phytopathogens Fusarium graminearum,
Alternaria alternata, Rhizoctonia solani, Cryphonectria parasitica and Phytophthora capsici [64]. So far, no
specific antimicrobial activity has been detected for B. borstelensis, P. dendritiformis and M. salipaludis,
which appears to be one of the novel findings of our study.
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Bacillus licheniformis 99 4.5 14 3 11 3 11
Bacillus sonorensis 99 3.8 12 2.8 10 3 11
Brevibacillus borstelensis 99 5 15 0.5 6 4.3 13.5
Bacillus vallismortis 99 2 9 4 13 0.5 6
Microbulbifer salipaludis 99 3.3 11 6.5 18 1 7
Bacillus subtilis 99 5 15 3 11 0.5 6
Aneurinibacillus migulanus 99 4 13 2 9 3.3 11.5
Aneurinibacillus migulanus 99 5.5 16 3 11 4.5 14
Paenibacillus dendritiformis 99 0.5 6 3 11 1 7
Paenibacillus dendritiformis 99 2 9 2 6 5 15
2.4. PCR-Screening for PKS and NRPS Domains
The 251 isolated strains were screened for the detection of genes involved in the synthesis of
bioactive compounds: polyketide synthases type I (PKS-I) and type II (PKS-II), and nonribosomal
peptide synthetases (NRPS) [65]. Although these enzymes are known to support synthesis of
bioactive secondary metabolites such as antibiotics [66,67], their presence does not imply expression or
functionality, but does increase the likelihood that the strain has the potential to produce antimicrobial
compounds such as antibiotics, antitumor agents, or immunosuppressants. Only 107 of the isolated
strains exhibited PCR products corresponding to at least one biosynthetic gene (see Supplementary
Table S1).
For the 49 isolates that exhibited antimicrobial activity, at least one type of biosynthetic gene
sequence was recovered from 25 strains. Of these 25 isolates, 56.0% were isolated from RHL,
and 48.0% have a genetic affiliation to genus Bacillus. NRPS biosynthetic genes were identified
in 40.8% of those selected strains, while PKS-I and PKS-II were identified in 28.5% and 20.4% of
isolates respectively (Supplementary Table S3). Six isolates were positive for all biosynthetic genes
screened: B. licheniformis (Bac84), B. vallismortis (Bac111), P. espejiana (Bac319), B. subtilis (Bac254) and
P. dendritiformis (Bac363 and Bac390). For the isolates that displayed zone inhibition against all of
the three indicator laboratory pathogens (Table 3), biosynthetic genes sequences were only found
in five isolates: B. licheniformis (Bac84), B. vallismortis (Bac111), B. subtilis (Bac254), P. dendritiformis
(Bac363 and Bac390). No biosynthetic gene sequences were recovered from the strains belonging to
B. borstelensis (Bac98) and M. salipaludis (Bac177), bacteria for which antimicrobial activity has been
reported in literature [68]. Additionally, from the 15 putative novel species (Table 2), biosynthetic
gene sequences were recovered from nine strains belonging to the following species: Microbulbifer
gwangyangensis (Bac85), Planctomyces brasiliensis (Bac 92), Bacillus simplex (Bac 94), Blastopirellula
cremea (Bac175), Brevibacterium avium (Bac181), Marinobacter xestospongiae (Bac216), P. atlantica (Bac288),
P. espejiana (Bac319) and Exiguobacterium profundum (Bac387).
Our study shows a rich biodiversity of culturable Firmicutes (Supplementary Table S2) from
Red Sea ecosystems on the Saudi Arabian coastline. Of all isolated strains, we found that 49 exhibit
potential antimicrobial activity. From these, 25 have at least one type of biosynthetic gene sequence,
indicating that these isolates are a valuable resource for the potential discovery of bioactive compounds.
Moreover, 75% of putative novel species and 67% of strains that exhibited antimicrobial activity were
isolated from RHL.
In this process we have also managed to short list 15 putative novel species that require
further experimentation to verify species novelty such as whole genome sequencing. In addition,
five additional strains (Bac 84, 111, 254, 363, 390) will be shortlisted for the purification and
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identification of their antimicrobial compounds using High Performance Liquid Chromotography
(HPLC), Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS).
3. Material and Methods
3.1. Sediment Sampling
Three types of sediment samples: mangrove mud (MN), microbial mat (MM), and barren soil (BS)
were collected from RHL (39◦0′35.762′ ′ E, 22◦45′5.582′ ′ N) and AKL (38◦54′39.638′ ′ E, 22◦54′50.251′ ′ N)
in Saudi Arabia (Figure 3). MN mud was sampled from the coastal lagoon of the Red Sea alongside
mangrove tree. MM was sampled approximately 7.5 m away from the coastal lagoon, while BS
represents sediment that did not come in contact with the lagoon water at high tide. All samples were
collected in triplicate from the same depth (2–25 cm), using a hollow steel tube (core sampler—each
core was 20–25 cm in length and 5 cm in diameter). Cores were kept on ice until the processing of
samples were done on the same day. Eight grams of wet weight sediment were homogenized at low
speed with 10 mL of sterilised Red Sea water. The supernatant (100 µL) was diluted five- and 25-fold,
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Figure 3. Map showing the sampling locations.
3.2. Isolation and Purification of Bacterial Strains
Several selective media types were used: actinomycetes isolation agar for cultivating
Actinobacteria, Difco Marine agar 2216 for cultivating heterotrophic bacteria, 10% Difco Marine
agar 2216 for cultivating oligotrophic bacteria, Difco Marine agar 2216 with 1 g/L streptomycin for
bacteria that are resistant to antibiotic, and Difco Marine broth 2216 gellan gum media for bacteria
that do not prefer agar (BD Difco, Franklin Lakes, NJ, USA). All media were prepared in artificial
seawater. Inoculated plates were incubated at 28 ◦C for up to 28 days and colonies were selected based
on morphology. After successive transfers, pure isolates were frozen at −80 ◦C in ddH2O (for DNA
extraction and amplification) and 30% glycerol solution for long-term storage.
3.3. Molecular Identification and Phylogenetic Analysis
Genomic DNA was prepared as described previously [69], but with slight modification of
the phenol-chloroform extraction and ethanol precipitation, which were done according to [70].
For 16S rRNA gene amplification, universal primers 27F primer (5′-AGAGTTTGATCMTGGCTCAG-3′)
and 1492R primer (5′-GGTTACCTTGTTACGACTT-3′), were used in the PCR reaction as previously
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described [71], with some parameters modified to the thermocycler (Bio-Rad, Hercules, CA, USA)
used. Initial denaturation occurred at 95 ◦C for 7 min, followed by 35 cycles of: denaturation at 95 ◦C
for 1 min, annealing at 54 ◦C for 45 s, and an extension at 72 ◦C for 90 min, with a final extension at 72 ◦C
for 5 min. Amplified DNA was electrophoresed on 1% agarose gel. The amplified PCR products of
bacterial gene fragments were purified according to the manufacturers recommendations: Nucleospin
recommended protocol (Macherey-Nagel GmbH, Düren, North Rhine-Westphalia, Germany). Purified
products were submitted for Sanger sequencing of the 16S rRNA gene at the King Abdullah University
of Science and Technology (KAUST) Bioscience Core Laboratory. The 16S rRNA gene sequences
were compared to sequences within the NCBI database using the Basic Local Alignment Search Tool
(BLAST). The phylogenetic tree was built in the ARB package [72], using the SILVA SSU Ref NR 99
(version 119) as the reference tree [73]. Alignment of the 16s rRNA genes (also referred to as species
in the text) was performed using SILVA’s SINA on-line aligner [74], with the variability profile set
to “Bacteria”, and all other parameters set to default. The alignment was inspected and edited in
the ARB package. Initially, we added our species to the reference tree using the parsimony method.
Close relatives of the reference tree were selected and a new tree was built using MrBayes [75] in
ARB (filter: bacteria, number of substitution type 4, number of cycles for Markov Chain Monte
Carlo = 100,000, number of chains = 6, temperature parameter for heating the chains = 0.5, Markov
chain sample frequency = 500). Thermogymnomonas acidicola (archaea) was added to the tree as an
outgroup. The 16S rRNA gene sequences of the isolates were deposited in GenBank under the
following accession numbers KP795796-KP795924 and KP980708-KP980808.
3.4. Screening for Antimicrobial Activity
Three pathogenic test laboratory strains (Staphylococcus aureus strain ATCC25923, Pseudomonas
syringae strain dc3000 and Salmonella typhimurium strain dT2) were used to analyze their sensitivity
towards the isolated stains. LB agar (Fisher BioReagents, Miller, Pittsburgh, PA, USA) was prepared
and autoclaved at 121 ◦C for 20 min. Stock cultures of the three pathogenic strains and all isolates
were cultured individually in LB agar plates and then incubated overnight at 37 ◦C. One of the grown
colonies was collected and mixed individually with 1 mL of LB broth in a 1.5 µL tube and incubated
at 37 ◦C, with shaking at 250 rpm overnight. A new LB agar plate was spread with a 100 µL aliquot of
an individual pathogenic strain. Next, the 10 µL aliquot of isolate suspension (optical density 600 nm
(OD600) of 0.5) was applied on the inoculated plate which was then incubated overnight aerobically
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Figure 4. Sketch depicting the an ular radius and iameter of the zone of inhibition.
3.5. PCR Screening for PKS and NRPS Gene Fragments
Specific primers used to screen for domains associated with the PKS and NRPS genes, are listed
in Table 4 [65,76]. The PCR products were electrophoresed on a 1% agarose gel, from which the bands
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of interest (NRPS: 700–800 bp; PKS-I: 1250–1400 bp; PKS-II: 800–900 bp) were cut out and purified
using the Wizard® SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA). PCR products
were cloned using pGEM®-T and pGEM®-T Easy vectors (Promega, Madison, WI, USA). Plasmids
that contain the PCR products were purified using the QIAprep® Spin Miniprep kit (Qiagen, Hilden,
North Rhine-Westphalia, Germany). PCR products were then sequenced and compared with PKS and
NRPS sequences in the NCBI database by using the Basic Local Alignment Search Tool X (BLASTX).
Table 4. Primers used to screen for domains associated with the PKS and NRPS genes.








Our study shows a rich biodiversity of culturable Firmicutes (Supplementary Table S2) from
Red Sea ecosystems on the Saudi Arabian coastline. Of all isolated strains, we found that 49 exhibit
potential antimicrobial activity. From these, 25 have at least one type of biosynthetic gene sequence,
indicating that these isolates are a valuable resource for the potential discovery of bioactive compounds.
Moreover, 75% of putative novel species and 67% of strains that exhibited antimicrobial activity were
isolated from RHL.
In this process, we have also managed to short list 15 putative novel species that require further
experimentation to verify species novelty such as whole genome sequencing. In addition, five
additional strains (Bac 84, 111, 254, 363, 390) will be shortlisted for the purification and identification
of their antimicrobial compounds using High Performance Liquid Chromotography (HPLC), Nuclear
Magnetic Resonance (NMR) and Mass Spectrometry (MS).
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/14/9/165/s1.
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